Difference between revisions of "Lipoprotein A (FXIIIa)"
m |
m |
||
| Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
! {{infobox header}}| '''{{PAGENAME}}''' | ! {{infobox header}}| '''{{PAGENAME}}''' | ||
| − | |||
| − | |||
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
Revision as of 14:15, 7 January 2008
| Template:Infobox header| Lipoprotein A (FXIIIa) | |
|---|---|
| Substrate peptide name | Lipoprotein A |
| Synonyms | Apolipoprotein A-I
Apo-AI |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Extracellular; plasma/extracellular space |
| Swissprot ID | P02647 |
| Reactive glutamines | Not determined yet |
| Reactive lysines | - |
| Substrate sequence | |
| Structure | 1AV1 |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:1680857 |
| Notes | |
| Template:Infobox header | |
